Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Similar documents
ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

Syringe driver in Palliative Care

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

SYRINGE DRIVER MEDICATIONS

Care of the Dying Management in Severe Renal Failure

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Algorithms for Symptom Management. In End of Life Care

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

Care of the Dying Management in Severe Renal Failure

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

Renal Palliative Care Last Days of Life

Symptom Management Guidelines for End of Life Care

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Supportive Care. End of Life Phase

End of life prescribing guidance

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Care in the Last Days of Life

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

Care of dying adults in the last days of life. Improving care at the very end of life.

Palliative Care Impact Survey

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Palliative care for heart failure patients. Susan Addie

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

End Stage Liver Disease Regional Audit Casenote Survey

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

BACKGROUND Measuring renal function :

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

Using syringe pumps in palliative care

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Clatterbridge Centre for Oncology

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Conservative Management of Uraemia

Syringe Drivers. Back to top

Palliative Care. Pocketbook 4

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Palliative Care Formulary

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Lothian Palliative Care Guidelines POCKET EDITION 2004

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

Palliative Prescribing - Pain

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

BJF Acute Pain Team Formulary Group

Eastern Health and Social Services Board Palliative Care

This survey aims to look at individual practice and can be completed by any healthcare professional.

Regional Renal Training

MND Just in Case kit Information for GPs

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Understanding pain in 5 minutes

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Isle of Wight Syringe Driver Compatibility Guidelines

Coversheet for Network Site Specific Group Agreed Documentation

What s New 2003? What new treatments? What have you discontinued? More information please!

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Analgesics: Management of Pain In the Elderly Handout Package

BREATHLESSNESS MANAGEMENT

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

PRIMARY CARE PALLIATIVE CARE FORMULARY

Implementing the recommendation on medication management and symptom control

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Guidelines for Syringe Driver Management in Palliative Care in New Zealand

East Kent Prescribing Group

SYMPTOM CONTROL MEDICATION & THE DYING PERSON LITERATURE REVIEW, & DRAFT NEW STANDARDS & GUIDELINES

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control

Planning for the future; A guide to symptom control at end of life in advanced dementia

Strong opioids for palliative care patients

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

AMBER Prescribing should only be undertaken in General Practice under the advice of the local hospice or specialist palliative care team.

PALLIATIVE CARE PRESCRIBING

NHS Grampian. Care Plan Palliative & Supportive. Acute Care Settings

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES. SECTION 3: End of Life Symptom Control. Berkshire Healthcare NHS Foundation Trust

The last days of life in hospital and at home

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre

Palliative care for patients with brain cancer

PALLIATIVE CARE PRESCRIBING

Bulletin Independent prescribing information for NHS Wales

survey Parenteral anti-epileptics What is your experience? May July 2015

1 (ix) Pain control. What responsibilities do you assume when you prescribe analgesia?

What else is new (other symptoms) DR ANDREW DAVIES

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza

Transcription:

Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients on Fentanyl should continue patch in addition to following guidelines. Please do not stop opiates in patients who are taking them regularly. PAIN Patient has pain which is not controlled Patient has no pain or pain is well controlled Is patient already taking oral morphine? Is patient already taking oral morphine? YES NO YES NO Convert to SC by dividing the total 24 hr dose of morphine by 3. As pain is not controlled the calculated dose of should be increased by 1/3 rd and administered via SC syringe driver over 24hrs. See palliative care guidelines and syringe driver policy. If this is ineffective contact the Specialist Palliative Care Team for advice. 2.5mg 5mg SC and prescribe this to be used PRN 1-2hrly 2) Start 10mg of /24hrs in a syringe driver 3) After 24 hrs review medication and, if the patient has needed breakthrough doses, increase the in the syringe driver proportional to the PRN diamorphine administered in past 24 hours Convert to SC by dividing total 24 hour dose oral Morphine by 3 e.g. Zomorph 30mg bd = 60mg morphine/24 hrs 60mg 3 = 20mg Prescribe 20mg iamorphine/24 hrs via SC syringe driver SC 1-2 hrly which should be equivalent to 1/6 of 24hr dose in syringe driver (e.g. 30mg /24hrs SC via syringe driver will require 5mg SC 2-4 hrly PRN) 2.5mg-5mg SC 1-2hrly 2) After 24hrs review medication and, if two or more doses required PRN, then start syringe driver of 5-10mg / 24hrs To convert from other strong opioids to a syringe driver please contact the Palliative Care Team or Pharmacy for advice. Palliative Care Team 7 days/week 9-5 Ext 3227 or ECT 7181 Out of hours Palliative Care Advice Line 07623 916125 1

oses must be proportional to the current benzodiazepine medication TERMINAL RESTLESSNESS AN AGITATION MIAZOLAM 2.5 5mg SC and prescribe this to be used 1-2 hrly PRN. MIAZOLAM 2.5 5mg SC 1-2 hrly 2) Start a syringe driver of MIAZOLAM 10mg/24 hrs 3) Review the required medication after 24hrs and if the patient has needed breakthrough doses, then increase the MIAZOLAM in the syringe driver to incorporate the additional amount required over the last 24hrs. 2) If two or more doses required PRN start syringe driver over 24hrs 10mg MIAZOLAM/ 24 hrs 4) Continue to give PRN doses accordingly. If patient unable to tolerate benzodiazepines use Levomepromazine 6.25mg stat SC and 2-4hrly PRN SC. If > 2 doses required in 24 hours start syringe driver of Levomepromazine 12.5mg/24 hrs. NNUH Palliative Care Team 7 days / week 9-5 Ext 3227 or ECT 7181 2

RESPIRATORY TRACT SECRETIONS 20mg SC 2) Start HYOSCINE BUTYLBROMIE 80mg in a syringe driver SC/24 hrs 3) Continue to give 20mg SC 2-4hrly if needed 1) Prescribe HYOSCINE BUTYLBROMIE 20mg SC 2-4hrly PRN 2) If two or more doses of PRN required, then start a syringe driver with 80mg SC/24hrs 4) Increase total 24hr dose to incorporate the additional amount administered during the past 24hours if symptoms persist Avoid using Hyoscine in patients with severe cardiac failure this can increase arrhythmias. For patients with severe cardiac failure use Glycopyronium Bromide 200 micrograms stat and 600micrograms/24 hours via syringe driver NNUH Palliative Care Team 7 days/ week 9-5 Ext 3227 or ECT 7181 3

oses must be proportional to the current anti-emetic medication NAUSEA AN VOMITING 6.25mg 2) Start syringe driver with 12.5-25 mg/ 24 hrs SC 3) Prescribe PRN dose of 6.25-12.5mg SC 2-4 hrly 1) Prescribe 6.25-12.5mg SC 2-4 hourly PRN 2) Review after 24 hours if 2 or more doses administered please start syringe driver of 12.5-25mg /24hrs SC 4) Review dose after 24hrs. If the patient is still nauseated / vomiting or has required breakthrough doses, then increase the dose of accordingly in the syringe driver to a maximum of 37.5mg IN 24 hours. 5) If nausea/vomiting not controlled seek specialist advice Alternative Anti-emetics HALOPERIOL 2.5mg SC STAT and 5 10mg / 24 hrs via syringe driver. CYCLIZINE 50mg SC PRN (100-150mg /24hr SC via syringe driver). Always use water for injections as diluent. Not compatible with Hyoscine Butylbromide or higher doses of Oxycodone; not recommended in patients with heart failure. METOCLOPRAMIE 10mg SC PRN (30-60 mg SC/24hrs via syringe driver ) Avoid in complete bowel obstruction; the prokinetic effect of Metoclopramide will be blocked with antimuscarinic drugs such as Hyoscine NNUH Palliative Care Team 7 days/week 9-5 Ext 3227 or ECT 7181 4

oses must be proportional according to current opiate/ benzodiazepine medication YSPNOEA (Breathlessness) Is patient taking oral MORPHINE for breathlessness? 2.5mg- 5mg SC PRN 1-2 hrly Yes No 1) Convert oral opiates to SC via a syringe driver (divide 24hr total oral Morphine dose by 3 to calculate 24hr SC iamorphine dose in mg) 2) Increase this calculated 24hr dose by 1/3 rd to alleviate breathlessness 3) Prescribe for breakthrough control of breathlessness (1/6 th of the total 24 hr iamorphine dose) 1) Give a stat dose 2.5mg-5mg SC 2) Start syringe driver 5-10mg/24 hrs 3) Prescribe 2.5-5 mg 1-2 hrly PRN for breakthrough control of breathlessness 4) If patient is breathless and anxious/agitated consider the use of MIAZOLAM 2.5mg SC stat or 5-10mg/24 hrs via syringe driver. 5) Prescribe Midazolam 2.5 mg PRN 2hrly SC NNUH Palliative Care Team Mon-Fri 9-5 Ext 3227 5